Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study

dc.contributor.author	Unal, Esra
dc.contributor.author	Aslan, Ezgi Lrmak
dc.contributor.author	Ozturk, Tulin
dc.contributor.author	Gomleksiz, Ozlem Kurnaz
dc.contributor.author	Kucukhuseyin, Ozlem
dc.contributor.author	Tuzuner, M. Bora
dc.contributor.author	Seyhan, M. Fatih
dc.contributor.author	Ozturk, Oguz
dc.contributor.author	Aydogan, Hulya Yilmaz
dc.date.accessioned	2021-12-21T08:47:30Z
dc.date.available	2021-12-21T08:47:30Z
dc.date.issued	2021
dc.identifier.issn	0006-2928
dc.identifier.issn	1573-4927
dc.identifier.uri	https://doi.org/10.1007/s10528-021-10068-5
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2251
dc.description.abstract	Breast cancer (BC) has a high incidence rate among women worldwide, and the mechanisms and etiology of this disease are not yet fully understood. The peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear hormone receptor that plays impor
dc.description.sponsorship	Scientific Research Projects Coordination Unit of Istanbul UniversityIstanbul University [:24082]
dc.language.iso	English
dc.publisher	Sprınger/Plenum Publıshers
dc.title	Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study
dc.type	Article
dc.relation.journal	Bıochemıcal Genetıcs
dc.identifier.issue	6
dc.identifier.startpage	1413
dc.identifier.endpage	1426
dc.identifier.volume	59
dc.identifier.doi	10.1007/s10528-021-10068-5
dc.relation.issue	6
dc.relation.volume	59